Cell ther­a­py biotech shifts fo­cus to UK, makes deep cuts to US head­count

It’s been less than two months since In­stil Bio re­vealed it would cut 60% of its US-based staff as the biotech scrapped its lead cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.